Panacea Index Logo

Command Palette

Search for a command to run...

Does the Ketogenic Diet Mediate Inflammation Markers in Obese and Overweight Adults? A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Nutrients
November 22, 2024
Mariangela Rondanelli et al. (7 authors)
Journal ArticleMeta-AnalysisSystematic ReviewHuman Study
Study Details

Study Goal

The researchers aimed to investigate the effects of a ketogenic diet on inflammatory biomarkers in overweight or obese individuals.

Results Summary

The study found a significant decrease in CRP levels and a slight, non-significant reduction in IL-6 levels after a ketogenic diet intervention. The results suggest the diet may help modulate inflammation in this population.

Population

Overweight or obese individuals

Effective Dosage

Not specified

Duration

8 weeks to 2 years

Interactions

None mentioned

Extracted Claims (3)
InterventionDirectionEndpointPopulationDosageImpactClaim #
ketogenic diet
decrease
CRP
overweight or obese individuals
mean of -0.62 mg/dL (95% CI: -0.84, -0,40)
significant decreases after treatment
#1
ketogenic diet
decrease
IL-6
overweight or obese individuals
mean of -1.31 pg/mL (95% CI: -2.86, 0.25)
slight, but not statistically significant, reduction
#2
ketogenic diet
decrease
inflammation
obese and overweight subjects
-
could contribute to modulating
#3
Abstract

Background/Objectives. The ketogenic diet has emerged as a potential treatment strategy for reducing inflammation. The purpose of this meta-analysis and systematic review is to look into how a ketogenic diet affects inflammatory biomarkers in persons who are overweight or obese. Methods. We conducted an extensive search of Web of Science, PubMed, Scopus, and Google Scholar to find pertinent studies reporting changes in inflammatory biomarkers such as C-reactive protein (CRP), the erythrocyte sedimentation rate, and cytokines after a ketogenic diet. Results. Seven randomized controlled trials involving 218 overweight or obese individuals who followed a ketogenic or control diet over 8 weeks to 2 years were included in the review, and five of those were considered for the meta-analysis. The primary outcomes were CRP and IL-6 levels. The results reported significant decreases after treatment for CRP (mean of -0.62 mg/dL (95% CI: -0.84, -0,40), and a slight, but not statistically significant, reduction in IL-6 (mean of -1.31 pg/mL (95% CI: -2.86, 0.25). Conclusions. The ketogenic diet could contribute to modulating inflammation in obese and overweight subjects.

Medical Subject Headings (MeSH)
AdultHumansBiomarkersC-Reactive ProteinDiet, KetogenicInflammationInterleukin-6ObesityOverweightRandomized Controlled Trials as Topic
Study Links
Quality Scores
SafetyNot Assessed
Efficacy75/10
Quality85/10
Research Impact Scores
APT Score0.05
Weight Score2.53
Normalized Score0.67
Related Supplements